Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of antibiotics during renal replacement therapy in ICU patients with acute kidney injury
ACTRN12613000241730Phase 2Completed
- Sponsor
- National Health and Medical Research Council
- Start
- Apr 2014
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 11
01
Overview
Phase 2, open-label trial of piperacillin + tazobactam, meropenem, vancomycin, imipenem and linezolid in bacterial disease (5 arms), sponsored by National Health and Medical Research Council. Primary endpoint: Description of pharmacokinetic parameters in various forms of renal replacement therapy. Started Apr 2014; status: completed.
02
Drugs
piperacillin + tazobactammeropenemvancomycinimipenemlinezolid
03
Conditions
bacterial disease
Beyond the preview
Go deeper on ACTRN12613000241730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000241730.